EC Number | Cloned (Comment) | Organism |
---|---|---|
3.5.2.6 | expressed in Escherichia coli | Mycobacterium tuberculosis |
3.5.2.6 | plasmid pET28b is transformed into Escherichia coli BL21(DE3) | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.5.2.6 | hanging drop vapour diffusion method with 0.1 M Tris-HCl, pH 8.0, 2.0 M NH4H2PO4 | Mycobacterium tuberculosis |
3.5.2.6 | hanging-drop vapour-diffusion method, 1.2 A resolution | Mycobacterium tuberculosis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
3.5.2.6 | additional information | the amino acid substitutions N132G, R164A, R244A, and R276E explain the broad specificity of the enzyme, relatively low penicillinase activity, and resistance to clavulanic acid | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.2.6 | clavulanate | - |
Mycobacterium tuberculosis | |
3.5.2.6 | clavulanic acid | poor inhibitor | Mycobacterium tuberculosis |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.5.2.6 | 0.063 | - |
ampicillin | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.063 | - |
ampicillin | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 0.117 | - |
cephalothin | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.117 | - |
cephalothin | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 0.195 | - |
cefoxitin | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.195 | - |
cefoxitin | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 0.279 | - |
meropenem | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.279 | - |
meropenem | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 0.593 | - |
ceftazidime | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.593 | - |
ceftazidime | at 30°C | Mycobacterium tuberculosis |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.5.2.6 | 30630 | - |
truncated protein, matrix-assisted laser desorption ionization | Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.2.6 | Mycobacterium tuberculosis | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.5.2.6 | - |
Mycobacterium tuberculosis |
3.5.2.6 | Ni2+-loaded HiTrap chelating column chromatography and Superdex 200 gel filtration | Mycobacterium tuberculosis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.2.6 | ampicillin + H2O | - |
Mycobacterium tuberculosis | (2R,4S)-2-[(R)-[[(2R)-2-amino-2-phenylacetyl]amino](carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | - |
? | |
3.5.2.6 | ampicillin + H2O | low activity | Mycobacterium tuberculosis | (2R,4S)-2-[(R)-[[(2R)-2-amino-2-phenylacetyl]amino](carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | - |
? | |
3.5.2.6 | cefoxitin + H2O | - |
Mycobacterium tuberculosis | (2R)-5-[(carbamoyloxy)methyl]-2-[(S)-carboxy(methoxy)[(thiophen-2-ylacetyl)amino]methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | - |
? | |
3.5.2.6 | ceftazidime + H2O | - |
Mycobacterium tuberculosis | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-[(pyridin-1-ium-1-yl)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate | - |
? | |
3.5.2.6 | cephalothin + H2O | - |
Mycobacterium tuberculosis | (2R)-5-[(acetyloxy)methyl]-2-[(R)-carboxy[(thiophen-2-ylacetyl)amino]methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | - |
? | |
3.5.2.6 | meropenem + H2O | - |
Mycobacterium tuberculosis | (4R,5S)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.2.6 | BlaC | - |
Mycobacterium tuberculosis |
3.5.2.6 | class A beta-lactamase | - |
Mycobacterium tuberculosis |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.5.2.6 | 0.2 | - |
ceftazidime | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.2 | - |
ceftazidime | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 0.9 | - |
meropenem | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.9 | - |
meropenem | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 1.1 | - |
cefoxitin | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 1.1 | - |
cefoxitin | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 12.1 | - |
cephalothin | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 12.1 | - |
cephalothin | at 30°C | Mycobacterium tuberculosis | |
3.5.2.6 | 18.5 | - |
ampicillin | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 18.5 | - |
ampicillin | at 30°C | Mycobacterium tuberculosis |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.5.2.6 | 0.0024 | - |
clavulanic acid | - |
Mycobacterium tuberculosis | |
3.5.2.6 | 0.0024 | - |
clavulanate | - |
Mycobacterium tuberculosis |